Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy results of the speckle tracking assisted resynchronization therapy for electrode region trial

Circulation: Heart Failure

Volumn 6, Issue 3, 2013, Pages 427-434

  Saba, Samir ^a   Marek, Josef ^a   Schwartzman, David ^a   Jain, Sandeep ^a   Adelstein, Evan ^a   White, Pamela ^a   Oyenuga, Olusegun A ^a   Onishi, Tetsuari ^a   Soman, Prem ^a   Gorcsan III, John ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cardiac resynchronization therapy; Death; Heart failure hospitalization; LV lead position

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CONTROLLED STUDY; DEVICE INFECTION; DEVICE REMOVAL; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPH; ECHOCARDIOGRAPHY; ELECTRODE IMPLANT; EVENT FREE SURVIVAL; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART FAILURE; HUMAN; IMPLANTATION; LEAD DISLODGEMENT; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PNEUMOTHORAX; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SPECKLE TRACKING ECHOCARDIOGRAPHY; TRANSVENOUS LEFT VENTRICULAR LEAD PLACEMENT;

CARDIAC RESYNCHRONIZATION THERAPY; DEATH; HEART FAILURE HOSPITALIZATION; LV LEAD POSITION; SPECKLE TRACKING ECHOCARDIOGRAPHY;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DOUBLE-BLIND METHOD; ELECTRODES, IMPLANTED; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGERY, COMPUTER-ASSISTED;

EID: 84879231801     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.000078     Document Type: Article

References (34)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
3. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
4. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators. Cardiacresynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-1338.
5. Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J. 2007;153:105-112.
6. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834-1840.
7. Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Saba SF, Gorcsan J 3rd. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J. 2011;32:93-103.
8. Suffoletto MS, Dohi K, Cannesson M, Saba S, Gorcsan J 3rd. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation. 2006;113:960-968.
9. Gorcsan J 3rd, Kanzaki H, Bazaz R, Dohi K, Schwartzman D. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol. 2004;93:1178-1181.
10. Yu CM, Gorcsan J 3rd, Bleeker GB, Zhang Q, Schalij MJ, Suffoletto MS, Fung JW, Schwartzman D, Chan YS, Tanabe M, Bax JJ. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol. 2007;100:1263-1270.
11. Delgado V, van Bommel RJ, Bertini M, Borleffs CJ, Marsan NA, Arnold CT, Nucifora G, van de Veire NR, Ypenburg C, Boersma E, Holman ER, Schalij MJ, Bax JJ. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation. 2011;123:70-78.
12. Gorcsan J 3rd. Finding pieces of the puzzle of nonresponse to cardiac resynchronization therapy. Circulation. 2011;123:10-12.
13. Becker M, Franke A, Breithardt OA, Ocklenburg C, Kaminski T, Kramann R, Knackstedt C, Stellbrink C, Hanrath P, Schauerte P, Hoffmann R. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study. Heart. 2007;93:1197-1203.
14. Bedi M, Suffoletro M, Tanabe M, Gorcsan J, Saba S. Effect of concordance between sites of left ventricular pacing and dyssynchrony on acute electrocardiographic and echocardiographic parameters in patients with heart failure undergoing cardiac resynchronization therapy. Clin Cardiol. 2006;29:498-502.
15. Fung JW, Lam YY, Zhang Q, Yip GW, Chan WW, Chan GC, Chan JY, Yu CM. Effect of left ventricular lead concordance to the delayed contraction segment on echocardiographic and clinical outcomes after cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2009;20:530-535.
16. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, Read PA, Begley D, Fynn SP, Dutka DP. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59:1509-1518.
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
18. Gorcsan J 3rd, Oyenuga O, Habib PJ, Tanaka H, Adelstein EC, Hara H, McNamara DM, Saba S. Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy. Circulation. 2010;122:1910-1918.
19. Hara H, Oyenuga OA, Tanaka H, Adelstein EC, Onishi T, McNamara DM, Schwartzman D, Saba S, Gorcsan J 3rd. The relationship of QRS morphology and mechanical dyssynchrony to long-term outcome following cardiac resynchronization therapy. Eur Heart J. 2012;33:2680-2691.
20. Gorcsan J 3rd. Echocardiographic assessment of ventricular dyssynchrony. Curr Heart Fail Rep. 2008;5:31-37.
21. Gorcsan J 3rd, Tanabe M, Bleeker GB, Suffoletto MS, Thomas NC, Saba S, Tops LF, Schalij MJ, Bax JJ. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol. 2007;50:1476-1483.
22. Khan FZ, Virdee MS, Read PA, Pugh PJ, O'Halloran D, Fahey M, Elsik M, Begley D, Fynn SP, Dutka DP. Effect of low-amplitude two-dimensional radial strain at left ventricular pacing sites on response to cardiac resynchronization therapy. J Am Soc Echocardiogr. 2010;23:1168-1176.
23. Mele D, Agricola E, Galderisi M, Rigo F, Citro R, Dal Monte A, Della Valentina P, Calabrese A, Ferrari R; Study Group of Echocardiography, Italian Society of Cardiology. Echocardiographic myocardial scar burden predicts response to cardiac resynchronization therapy in ischemic heart failure. J Am Soc Echocardiogr. 2009;22:702-708.
24. Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, Picard MH, Polk DM, Ragosta M, Parker Ward R, Weiner RB. ACCF/ ASE/AHA/ASNC/HFSA/HRS/ SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr. 2011;24:229-267.
25. Gorcsan J 3rd, Zareba W, Pouleur AC, Knappe D, Kutyifa V, Moss AJ, Solomon SD. Baseline radial dyssynchrony by speckle tracking echocardiography is associated with favorable clinical outcomes after cardiac resynchronization therapy: analysis from the MADIT-CRT trial (abstract). Circulation. 2012;126:A13288.
26. Foley PW, Chalil S, Ratib K, Smith R, Prinzen F, Auricchio A, Leyva F. Fluoroscopic left ventricular lead position and the long-term clinical outcome of cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2011;34:785-797.
27. Butter C, Auricchio A, Stellbrink C, Fleck E, Ding J, Yu Y, Huvelle E, Spinelli J; Pacing Therapy for Chronic Heart Failure II Study Group. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation. 2001;104:3026-3029.
28. Butter C, Auricchio A, Stellbrink C, Schlegl M, Fleck E, Hörsch W, Huvelle E, Ding J, Kramer A; Pacing Therapies in Congestive Heart Failure II Study Group. Should stimulation site be tailored in the individual heart failure patient? Am J Cardiol. 2000;86:144K-151K.
29. Murphy RT, Sigurdsson G, Mulamalla S, Agler D, Popovic ZB, Starling RC, Wilkoff BL, Thomas JD, Grimm RA. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol. 2006;97:1615-1621.
30. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ, Bax JJ. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol. 2009;53:483-490.
31. Helm RH, Byrne M, Helm PA, Daya SK, Osman NF, Tunin R, Halperin n, Berger RD, Kass DA, Lardo AC. Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Circulation. 2007;115:953-961.
32. Burger H, Kempfert J, van Linden A, Szalay Z, Schoenburg M, Walther T, Ziegelhoeffer T. Endurance and performance of two different concepts for left ventricular stimulation with bipolar epicardial leads in long-term follow-up. Thorac Cardiovasc Surg. 2012;60:70-77.
33. Scott PA, Yue AM, Watts E, Zeb M, Roberts PR, Morgan JM. Transseptal left ventricular endocardial pacing reduces dispersion of ventricular repolarization. Pacing Clin Electrophysiol. 2011;34:1258-1266.
34. Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de Roos A, van der Wall EE, Schalij MJ, Bax JJ. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113:969-976.